AllianceBernstein’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-2,378
Closed -$590K – 3367
2026
Q1
$590K Hold
2,378
– – ﹤0.01% 2553
2025
Q4
$590K Buy
2,378
+1,144
+93% +$261K ﹤0.01% 2572
2025
Q3
$260K Buy
1,234
+904
+274% +$159K ﹤0.01% 2990
2025
Q2
$32.5K Buy
+330
New +$28.8K ﹤0.01% 3219
2023
Q4
– Sell
-1,853
Closed -$123K – 3190
2023
Q3
$123K Hold
1,853
– – ﹤0.01% 3038
2023
Q2
$178K Sell
1,853
-760
-29% -$75.7K ﹤0.01% 3009
2023
Q1
$263K Sell
2,613
-12
-0.5% -$1.84K ﹤0.01% 2819
2022
Q4
$456K Hold
2,625
– – ﹤0.01% 2679
2022
Q3
$2.52M Buy
2,625
+2,002
+321% +$1.99M ﹤0.01% 1738
2022
Q2
$417K Hold
623
– – ﹤0.01% 2752
2022
Q1
$432K Buy
623
+2
+0.3% +$1.54K ﹤0.01% 2738
2021
Q4
$562K Hold
621
– – ﹤0.01% 2681
2021
Q3
$625K Sell
621
-70
-10% -$51.6K ﹤0.01% 2671
2021
Q2
$449K Sell
691
-1,017
-60% -$705K ﹤0.01% 2856
2021
Q1
$1.26M Sell
1,708
-96
-5% -$77.4K ﹤0.01% 2312
2020
Q4
$1.4M Sell
1,804
-27,050
-94% -$21.3M ﹤0.01% 2163
2020
Q3
$28.6M Buy
28,854
+1,249
+5% +$1.32M 0.02% 693
2020
Q2
$28.7M Buy
27,605
+4,650
+20% +$4.68M 0.02% 657
2020
Q1
$18.6M Buy
22,955
+1,192
+5% +$1.25M 0.01% 707
2019
Q4
$27.2M Sell
21,763
-1,130
-5% -$1.82M 0.02% 716
2019
Q3
$30.8M Buy
22,893
+2,627
+13% +$4.18M 0.02% 658
2019
Q2
$36M Buy
20,266
+2,854
+16% +$4.37M 0.02% 633
2019
Q1
$30.2M Buy
+17,412
New +$29M 0.02% 683

Other funds holding GOSS

AllianceBernstein's GOSS Position: Q2 2026 in Review

AllianceBernstein sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 2,378 shares — an estimated $590K sold.

AllianceBernstein first reported a position in GOSS in Q1 2019 and held it in 23 quarters. The position peaked at $36M in Q2 2019. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • AllianceBernstein reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • AllianceBernstein sold 2,378 Gossamer Bio shares in Q2 2026, an estimated $590K.
  • AllianceBernstein first reported a position in Gossamer Bio in Q1 2019 and held it in 23 quarters.
  • AllianceBernstein's Gossamer Bio position peaked at $36M in Q2 2019.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.